Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome In Vitro by Pharmacological Inhibition of Cdc42-Induced Actin Cytoskeleton Remodeling
Authors:
Open Access
- 24 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Abstract
Natural killer (NK) cells are innate effector lymphocytes with strong antitumor effects against hematologic malignancies such as chronic lymphocytic leukemia (CLL). However, NK cells fail to control CLL progression on the long term. For effective lysis of their targets, NK cells use a specific cell-cell interface, known as the immunological synapse (IS), whose assembly and effector function critically rely on dynamic cytoskeletal changes in NK cells. Here we explored the role of CLL cell actin cytoskeleton during NK cell attack. We found that CLL cells can undergo fast actin cytoskeleton remodeling which is characterized by a NK cell contact-induced accumulation of actin filaments at the IS. Such polarization of the actin cytoskeleton was strongly associated with resistance against NK cell-mediated cytotoxicity and reduced amounts of the cell-death inducing molecule granzyme B in target CLL cells. Selective pharmacological targeting of the key actin regulator Cdc42 abrogated the capacity of CLL cells to reorganize their actin cytoskeleton during NK cell attack, increased levels of transferred granzyme B and restored CLL cell susceptibility to NK cell cytotoxicity. This resistance mechanism was confirmed in primary CLL cells from patients. In addition, pharmacological inhibition of actin dynamics in combination with blocking antibodies increased conjugation frequency and improved CLL cell elimination by NK cells. Together our results highlight the critical role of CLL cell actin cytoskeleton in driving resistance against NK cell cytotoxicity and provide new potential therapeutic point of intervention to target CLL immune escape.Keywords
Funding Information
- Fonds National de la Recherche Luxembourg (C19/BM/13579644, INTER/DFG/16/11509946)
- Fonds De La Recherche Scientifique - FNRS (7.4536.19, 7.4531.20, 7.4503.19)
- Fondation Cancer (ACTIMMUNE, FC/2019/02)
This publication has 80 references indexed in Scilit:
- A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor CellsCancer Research, 2013
- Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Haematologica, 2010
- TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutationsLeukemia, 2010
- Cytotoxic immunological synapsesImmunological Reviews, 2010
- ILT2/HLA‐G interaction impairs NK‐cell functions through the inhibition of the late but not the early events of the NK‐cell activating synapseThe FASEB Journal, 2009
- Resistance of Tumor Cells to Cytolytic T Lymphocytes Involves Rho-GTPases and Focal Adhesion Kinase ActivationJournal of Biological Chemistry, 2008
- Formation and function of the lytic NK-cell immunological synapseNature Reviews Immunology, 2008
- Lifeact: a versatile marker to visualize F-actinNature Methods, 2008
- Regulation of Actin Filament Assembly by Arp2/3 Complex and ForminsAnnual Review of Biophysics, 2007
- HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaBlood, 2005